COVID-19: An unexpected pandemic challenge to unprepared health care systems
ESCMID eAcademy. Faculty / Presenter(s) . 04/10/20; 291571
Jesús Rodríguez-Baño
Maurizio Sanguinetti
Nicola Petrosillo
Önder Ergönül
Eskild Petersen
Marion Koopmans
Jordi Vila
Benedetta Allegranzi
Massimo Antonelli
About this activity
Abstract
This Open-Access webinar (no login required) took place on April 10th, 2020 16:00 - 18:15 CEST (GMT: 2pm - 4:15pm) and is now available for On-Demand access with slide navigation.
ESCMID Webinar COVID-19: An unexpected pandemic challenge to unprepared health care systems
ESCMID Webinar COVID-19: An unexpected pandemic challenge to unprepared health care systems
- ESCMID Welcome (Jesus Rodriguez Bano, Maurizio Sanguinetti)
- Introduction: EITaF Team (Nicola Petrosillo, Onder Ergonul, Eskild Petersen)
- Diagnostics: PCR, serology and else (Jordi Vila, Clinical Microbiology, Barcelona, Spain)
- Q/A (All Faculty)
- Infection Prevention & Control in the healthcare setting (Benedetta Allegranzi, WHO, Geneva)
- Case management and therapy - in the acute ward (Jesus Rodriguez Bano, Infectious Diseases, Sevilla, Spain)
- 1Case management and therapy - in intensive care (Massimo Antonelli, Intensive Care, Catholic University, Rome, Italy)
- Q/A and Conclusions (All Faculty)
Summary: ESCMID Webinar on COVID-19: An unexpected pandemic challenge to unprepared health care systems
Dr. Hans-Christian Zaun, Ph.D.
Scientific Advisor, MULTILEARNING GROUP.
This webinar discussed numerous aspects of the COVID-19 pandemic that has gripped the globe over the past several months. This webinar covered a variety of topics that began with a discussion on different testing and diagnostic assays by Dr. Jordi Vila of the Clinical Microbiology Department at the University of Barcelona, Spain. Dr. Vila reviewed the three main leading methods to test for SARS-CoV-2 infection; RT-PCR, viral antigen detection, and presence of SARS-CoV-2 antibodies, as well as the difficulties of each assay. Finally, Dr. Vila stressed the importance of obtaining good samples for optimal diagnostic results.
Dr. Benedetta Allegranzi of the World Health Organization in Geneva, Switzerland, followed by discussing preparedness and infection prevention in the healthcare setting, including standard precautions and proper use of personal protective equipment, particularly the rational use PPE during times of shortages and use of masks.
Drs. Jesus Rodriguez Bano of the Infection Diseases Division at the Hospital Universitario Virgen Macarena, Sevilla, Spain, and Massimo Antonelli of the Department of Intensive Care and Anesthesiology, Catholic University, Rome, Italy, discussed case management and treatment.
Dr. Bano began by offering recommendations on hospital and patient management and reviewing preliminary results of possible pharmacological interventions, as well as the debates and controversies surrounding many of these treatments, particularly the combination of hydroxychloroquine and Azithromycin. He stressed that practitioners must be wary, as there are currently no recommended treatments for COVID-19, and a majority of these studies are preliminary research outside a clinical setting. Finally, Dr. Antonelli reviewed the situation in Italy as an opportunity for the healthcare communities of other countries to learn from this experience, such as the massive difficulties doctors had to face in Lombardy with so many patients requiring admittance to a limited number of ICUs.
Dr. Hans-Christian Zaun, Ph.D.
Scientific Advisor, MULTILEARNING GROUP.
This webinar discussed numerous aspects of the COVID-19 pandemic that has gripped the globe over the past several months. This webinar covered a variety of topics that began with a discussion on different testing and diagnostic assays by Dr. Jordi Vila of the Clinical Microbiology Department at the University of Barcelona, Spain. Dr. Vila reviewed the three main leading methods to test for SARS-CoV-2 infection; RT-PCR, viral antigen detection, and presence of SARS-CoV-2 antibodies, as well as the difficulties of each assay. Finally, Dr. Vila stressed the importance of obtaining good samples for optimal diagnostic results.
Dr. Benedetta Allegranzi of the World Health Organization in Geneva, Switzerland, followed by discussing preparedness and infection prevention in the healthcare setting, including standard precautions and proper use of personal protective equipment, particularly the rational use PPE during times of shortages and use of masks.
Drs. Jesus Rodriguez Bano of the Infection Diseases Division at the Hospital Universitario Virgen Macarena, Sevilla, Spain, and Massimo Antonelli of the Department of Intensive Care and Anesthesiology, Catholic University, Rome, Italy, discussed case management and treatment.
Dr. Bano began by offering recommendations on hospital and patient management and reviewing preliminary results of possible pharmacological interventions, as well as the debates and controversies surrounding many of these treatments, particularly the combination of hydroxychloroquine and Azithromycin. He stressed that practitioners must be wary, as there are currently no recommended treatments for COVID-19, and a majority of these studies are preliminary research outside a clinical setting. Finally, Dr. Antonelli reviewed the situation in Italy as an opportunity for the healthcare communities of other countries to learn from this experience, such as the massive difficulties doctors had to face in Lombardy with so many patients requiring admittance to a limited number of ICUs.
Summary: ESCMID Webinar on COVID-19: An unexpected pandemic challenge to unprepared health care systems
Dr. Hans-Christian Zaun, Ph.D.
Scientific Advisor, MULTILEARNING GROUP.
This webinar discussed numerous aspects of the COVID-19 pandemic that has gripped the globe over the past several months. This webinar covered a variety of topics that began with a discussion on different testing and diagnostic assays by Dr. Jordi Vila of the Clinical Microbiology Department at the University of Barcelona, Spain. Dr. Vila reviewed the three main leading methods to test for SARS-CoV-2 infection; RT-PCR, viral antigen detection, and presence of SARS-CoV-2 antibodies, as well as the difficulties of each assay. Finally, Dr. Vila stressed the importance of obtaining good samples for optimal diagnostic results.
Dr. Benedetta Allegranzi of the World Health Organization in Geneva, Switzerland, followed by discussing preparedness and infection prevention in the healthcare setting, including standard precautions and proper use of personal protective equipment, particularly the rational use PPE during times of shortages and use of masks.
Drs. Jesus Rodriguez Bano of the Infection Diseases Division at the Hospital Universitario Virgen Macarena, Sevilla, Spain, and Massimo Antonelli of the Department of Intensive Care and Anesthesiology, Catholic University, Rome, Italy, discussed case management and treatment.
Dr. Bano began by offering recommendations on hospital and patient management and reviewing preliminary results of possible pharmacological interventions, as well as the debates and controversies surrounding many of these treatments, particularly the combination of hydroxychloroquine and Azithromycin. He stressed that practitioners must be wary, as there are currently no recommended treatments for COVID-19, and a majority of these studies are preliminary research outside a clinical setting. Finally, Dr. Antonelli reviewed the situation in Italy as an opportunity for the healthcare communities of other countries to learn from this experience, such as the massive difficulties doctors had to face in Lombardy with so many patients requiring admittance to a limited number of ICUs.
Dr. Hans-Christian Zaun, Ph.D.
Scientific Advisor, MULTILEARNING GROUP.
This webinar discussed numerous aspects of the COVID-19 pandemic that has gripped the globe over the past several months. This webinar covered a variety of topics that began with a discussion on different testing and diagnostic assays by Dr. Jordi Vila of the Clinical Microbiology Department at the University of Barcelona, Spain. Dr. Vila reviewed the three main leading methods to test for SARS-CoV-2 infection; RT-PCR, viral antigen detection, and presence of SARS-CoV-2 antibodies, as well as the difficulties of each assay. Finally, Dr. Vila stressed the importance of obtaining good samples for optimal diagnostic results.
Dr. Benedetta Allegranzi of the World Health Organization in Geneva, Switzerland, followed by discussing preparedness and infection prevention in the healthcare setting, including standard precautions and proper use of personal protective equipment, particularly the rational use PPE during times of shortages and use of masks.
Drs. Jesus Rodriguez Bano of the Infection Diseases Division at the Hospital Universitario Virgen Macarena, Sevilla, Spain, and Massimo Antonelli of the Department of Intensive Care and Anesthesiology, Catholic University, Rome, Italy, discussed case management and treatment.
Dr. Bano began by offering recommendations on hospital and patient management and reviewing preliminary results of possible pharmacological interventions, as well as the debates and controversies surrounding many of these treatments, particularly the combination of hydroxychloroquine and Azithromycin. He stressed that practitioners must be wary, as there are currently no recommended treatments for COVID-19, and a majority of these studies are preliminary research outside a clinical setting. Finally, Dr. Antonelli reviewed the situation in Italy as an opportunity for the healthcare communities of other countries to learn from this experience, such as the massive difficulties doctors had to face in Lombardy with so many patients requiring admittance to a limited number of ICUs.
{{ help_message }}
{{filter}}